HemoCue Logo white

Public Health

By providing access to accurate screening tools, you can protect the children who will be shaping our future. We would be delighted to be your partner in the continuation, or establishment, of your public health initiatives. We will be your sustainable partner from initiation to implementation – and onwards.

Public health refers to, according to WHO, all organized measures (whether public or private) to prevent disease, promote health, and prolong life among the population as a whole. Its activities focus on entire populations instead of individual patients or diseases and aim to provide conditions where people can be healthy. This is why activities, like screening programs, are usually performed under the public health umbrella.

Similar to diabetes being common in some countries, anemia presents a major public health burden in many low- and middle-income countries (LMICs). Pregnant women and preschool children are especially at risk and left untreated, anemia may have devastating effects on the prosperity of an entire society. To be able to reach the United Nations’ Sustainable Development Goals, actions that are holistic and sustainable need to be taken. Child mortality is decreasing in many countries due to well-executed immunization programs – now we need to ensure that these children not only survive but thrive.

Anemia is a symptom that can be present in various circumstances like malaria, malnutrition, HIV, AIDS, and hemoglobinopathies, but also in chronic diseases. If we start to see beyond just one diagnosis and look at the individual, that person may have a higher chance to thrive, as does the society in which he/she lives. But we must deal with the anemia, treat its cause and monitor its progress.

The next question would be: Where do we start? Where do we make the most impact? It starts within the first 1.000 days of a baby’s life. That is when, to some extent, their future is being set. A healthy pregnant mother with no anemia will have a better chance of giving birth to a healthy baby and taking good care of that baby. Without anemia at birth, that baby will have a higher chance to live a full life.

Solutions at hand

With HemoCue, we can make it easy to detect those at risk and take action. By providing access to accurate screening tools for public health-related programs, whether in a hospital or the field, you can protect the children who will be shaping our future. Wherever they are. One drop of blood in combination with HemoCue point-of-care testing systems can make a difference.

HemoCue point-of-care testing systems give quick and reliable results with laboratory quality for Hb, glucose, and HbA1c and support in ruling in or ruling out infections. The analyzers are small and portable, making them ideal for use in mobile hospitals, maternity clinics, health posts and in community health care by community health workers. With these systems at hand, you have a useful portfolio of tools to manage the following at the point of care:

  • Screening and monitoring of anemia
  • Screening, monitoring and aiding in diagnosing diabetes

HemoCue® Hb 801 System

Innovation at its best. The Hb 801 provides ease of use and enables workflow efficiency with connectivity capabilities delivering fast results at the time of care.

HemoCue® Hb 201+ System

Providing lab accuracy and ease of use, the HemoCue® 201+ System has become a standard in hemoglobin point-of-care testing.

HemoCue® Hb 301 System

Optimized for anemia screening in primary care and blood donation settings.

HemoCue® Glucose 201+ System

Measures blood glucose levels in the diabetes management. The unique microcuvette technology gives high accuracy and reduces contamination risks.

HemoCue® Glucose 201 RT System

Portable and battery-operated system with room temperature microcuvette storage.

HemoCue® HbA1c 501 System

Fully automated POCT system for measuring HbA1c, providing efficient workflow for patient care.

Download PDF “The case for action on anemia”











    I’d like to receive HemoCue news and information via my preferred channel marked below. I understand that I can opt out at any time.



    Learn more about Anemia & Diabetes

    HemoCue Logo white

    www.hemocue.com

    © 2024 HemoCue

    HemoCue AB
    Kuvettgatan 1
    SE-262 71
    Ängelholm
    Sweden
    Phone: +46 77 570 02 10
    Email: marcom@hemocue.se
    Website: www.hemocue.com